New Key Statistics Module, Z-Score and F-Score
NAS:BMRN Key Ratios
Market Cap $ M | 15,812.90 |
Enterprise Value $ M | 15,834.84 |
P/E(ttm) | 95.24 |
PE Ratio without NRI | 47.62 |
Forward PE Ratio | 31.25 |
Price/Book | 3.19 |
Price/Sales | 6.66 |
Price/Free Cash Flow | 307.00 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 2,419.00 |
EPS (TTM) $ | 0.88 |
Beneish M-Score | -2.14 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 14.40 |
EV-to-EBIT | 77.13 |
EV-to-EBITDA | 51.13 |
PEG | -- |
Shares Outstanding M | 188.68 |
Net Margin (%) | 6.93 |
Operating Margin % | 6.53 |
Pre-tax Margin (%) | 7.79 |
Quick Ratio | 1.57 |
Current Ratio | 2.51 |
ROA % (ttm) | 2.54 |
ROE % (ttm) | 3.51 |
ROIC % (ttm) | 2.81 |
Dividend Yield % | -- |
Altman Z-Score | 5.66 |
Piotroski F-Score | 6.00 |
Positive ROA | Y |
Positive CFROA | Y |
Higher ROA y-y | Y |
Cash flow > Earnings | N |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | Y |
Higher Asset Turnover y-y | Y |
BMRN Number of Guru Trades
BMRN Volume of Guru Trades
Gurus Latest Trades with NAS:BMRN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BMRN is held by these investors
Total 5
Biomarin Pharmaceutical Inc Insider Transactions
No Available Data
News about NAS:BMRN
Total 0- 1